MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is moving toward commercial deployment of its voice-based artificial intelligence platform for detecting drug and alcohol impairment, with a focus on industrial safety applications in South America's mining sector. The company recently appointed Chilean drug policy specialist Felipe Leyton to lead commercialization in the region, signaling a strategic push into the mining industry.
The company's technology analyzes voice patterns to detect intoxication or impairment without biological testing, positioning it as a scalable tool for workplace safety in high-risk industries. Chile's mining sector, which employs more than 200,000 workers, represents an early target market for the platform, which is expected to begin deployment in industrial environments in 2026.
MindBio also recently closed an upsized non-brokered private placement of up to $1.5 million to support commercialization activities. The company's move into the mining sector comes as part of a broader strategy to address workplace safety concerns, particularly in industries where impairment can lead to serious accidents.
Felipe Leyton, the newly appointed commercialization lead, brings expertise in drug policy and regulatory frameworks in South America. His role will be to navigate the regulatory landscape and establish partnerships with mining companies. The appointment underscores MindBio's commitment to tailoring its technology for the region's specific needs.
The voice-based impairment detection platform offers an alternative to traditional biological testing methods, such as breathalyzers or saliva tests. By analyzing vocal biomarkers, the system can provide real-time results without requiring physical samples, making it suitable for high-throughput screening in industrial settings.
For more information, visit the company's newsroom at https://ibn.fm/MBQIF.
MindBio's focus on the mining sector aligns with global trends toward AI-driven safety solutions. The company believes its platform can reduce impairment-related incidents and improve overall safety metrics. As the platform moves toward commercial deployment, MindBio is positioning itself as a key player in the industrial safety technology market.
